metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Differences between agalsidase α and agalsidase β in the treatment of Fabry di...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Differences between agalsidase α and agalsidase β in the treatment of Fabry disease
Diferencias entre agalsidasa α y agalsidasa β en el tratamiento de la enfermedad de Fabry
Jordi Pérez-Lópeza,
Corresponding author
jordpere@vhebron.net

Corresponding author.
, Alfonso Domínguez Gil-Hurléb, Mónica López Rodríguezc
a Errores Congénitos del Metabolismo en Pacientes Adultos, Unidad de Enfermedades Minoritarias, Hospital Vall d’Hebron, Barcelona, Spain
b Departamento de Farmacia y Tecnología Farmacéutica, Universidad de Salamanca, Salamanca, Spain
c Servicio de Medicina Interna, Hospital Central de la Cruz Roja, Madrid, Spain
Read
10
Times
was read the article
3
Total PDF
7
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2021 April 1 0 1
2020 May 6 2 8
2017 October 0 1 1

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos